Michael E. Farkouh

Michael E. Farkouh's AcademicInfluence.com Rankings

Michael E. Farkouh

Medical

#2464

World Rank

#2891

Historical Rank

Cardiology

#226

World Rank

#232

Historical Rank

medical Degrees

Michael E. Farkouh

Philosophy

#7150

World Rank

#10321

Historical Rank

Logic

#4220

World Rank

#5485

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Why Is Michael E. Farkouh Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Michael E. Farkouh's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Strategies for multivessel revascularization in patients with diabetes. (2012) (1569)
Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials (2013) (1418)
Users' Guides to the Medical Literature: III. How to Use an Article About a Diagnostic Test A. Are the Results of the Study Valid? (1994) (1006)
Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. (1996) (872)
Users' Guides to the Medical Literature: II. How to Use an Article About Therapy or Prevention B. What Were the Results and Will They Help Me in Caring for My Patients? (1994) (681)
Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials. (2014) (659)
Users' Guides to the Medical Literature: I. How to Get Started (1993) (576)
Testing of low-risk patients presenting to the emergency department with chest pain: a scientific statement from the American Heart Association. (2010) (557)
A clinical trial of a chest-pain observation unit for patients with unstable angina. Chest Pain Evaluation in the Emergency Room (CHEER) Investigators. (1998) (553)
Users' Guides to the Medical Literature: V. How to Use an Article About Prognosis (1994) (520)
Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial (2011) (509)
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19 (2021) (508)
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19 (2021) (485)
Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial (2004) (483)
Atherosclerosis Inflammation Imaging with 18F-FDG PET: Carotid, Iliac, and Femoral Uptake Reproducibility, Quantification Methods, and Recommendations (2008) (455)
(18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials. (2007) (428)
The Antioxidant Vitamins and Cardiovascular Disease: A Critical Review of Epidemiologic and Clinical Trial Data (1995) (425)
Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data (2018) (423)
Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis. (2013) (404)
Intensification of statin therapy results in a rapid reduction in atherosclerotic inflammation: results of a multicenter fluorodeoxyglucose-positron emission tomography/computed tomography feasibility study. (2013) (370)
Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis (2010) (337)
Inflammation, Immunity, and Infection in Atherothrombosis: JACC Review Topic of the Week. (2018) (330)
Users' Guides to the Medical Literature: IV. How to Use an Article About Harm (1994) (328)
Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity (2010) (283)
Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With COVID-19 (2020) (259)
Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: study design and rationale. (2004) (246)
Relationships Among Regional Arterial Inflammation, Calcification, Risk Factors, and Biomarkers: A Prospective Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography Imaging Study (2009) (241)
A polypill strategy to improve adherence: results from the FOCUS project. (2014) (232)
AKI and Long-Term Risk for Cardiovascular Events and Mortality. (2017) (224)
Strengths and limitations of meta-analysis: larger studies may be more reliable. (1997) (219)
Disease Activity in Rheumatoid Arthritis and the Risk of Cardiovascular Events (2015) (216)
Glucose-lowering drugs or strategies and cardiovascular outcomes in patients with or at risk for type 2 diabetes: a meta-analysis of randomised controlled trials. (2015) (214)
Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options. (2008) (206)
Effect of Empagliflozin on Left Ventricular Mass in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease (2019) (200)
Design of the Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) Trial. (2008) (196)
Association of myocardial enzyme elevation and survival following coronary artery bypass graft surgery. (2011) (189)
Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary Intervention: The TAILOR-PCI Randomized Clinical Trial. (2020) (187)
Comparison of coronary artery bypass surgery and percutaneous coronary intervention in patients with diabetes: a meta-analysis of randomised controlled trials. (2013) (187)
A polypill strategy to improve adherence: results from FOCUS (Fixed-dose Combination Drug for Secondary Cardiovascular Prevention) Project (2014) (174)
Sex differences in evaluation and outcome of unstable angina. (2000) (164)
Anticoagulation, Mortality, Bleeding and Pathology Among Patients Hospitalized with COVID-19: A Single Health System Study (2020) (163)
Multimodality imaging of atherosclerotic plaque activity and composition using FDG-PET/CT and MRI in carotid and femoral arteries. (2009) (159)
The HOPE (Heart Outcomes Prevention Evaluation) Study: the design of a large, simple randomized trial of an angiotensin-converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events. The HOPE study investigators. (1996) (155)
Appropriate cardiac cath lab activation: optimizing electrocardiogram interpretation and clinical decision-making for acute ST-elevation myocardial infarction. (2010) (144)
Risk factor control for coronary artery disease secondary prevention in large randomized trials. (2013) (144)
Quality of life after PCI vs CABG among patients with diabetes and multivessel coronary artery disease: a randomized clinical trial. (2013) (142)
Long-Term Survival Following Multivessel Revascularization in Patients With Diabetes: The FREEDOM Follow-On Study. (2019) (141)
Long-term outcome of PCI versus CABG in insulin and non-insulin-treated diabetic patients: results from the FREEDOM trial. (2014) (140)
Underutilization of high-intensity statin therapy after hospitalization for coronary heart disease. (2015) (139)
An evidence-based review of the cardiovascular risks of nonsteroidal anti-inflammatory drugs. (2009) (132)
Canadian Cardiovascular Society guidelines for the diagnosis and management of stable ischemic heart disease. (2014) (129)
Effect of Empagliflozin on Left Ventricular Mass in Patients with Type 2 Diabetes and Coronary Artery Disease: The EMPA-HEART CardioLink-6 Randomized Clinical Trial. (2019) (128)
Role of insulin resistance and hyperglycemia in the development of atherosclerosis. (2007) (123)
Derivation and Internal Validation of an Expanded Cardiovascular Risk Prediction Score for Rheumatoid Arthritis: A Consortium of Rheumatology Researchers of North America Registry Study (2015) (118)
Cost-Effectiveness of Percutaneous Coronary Intervention With Drug Eluting Stents Versus Bypass Surgery for Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease: Results From the FREEDOM Trial (2013) (115)
Cardiovascular outcomes in high risk patients with osteoarthritis treated with ibuprofen, naproxen or lumiracoxib (2007) (112)
High-dose atorvastatin reduces periodontal inflammation: a novel pleiotropic effect of statins. (2013) (111)
Optimizing 18F-FDG PET/CT imaging of vessel wall inflammation: the impact of 18F-FDG circulation time, injected dose, uptake parameters, and fasting blood glucose levels (2014) (109)
Defining an Intraoperative Hypotension Threshold in Association with Stroke in Cardiac Surgery (2018) (108)
The vulnerable plaque and acute coronary syndromes. (2002) (104)
Comprehensive Cardiovascular Risk Factor Control Improves Survival: The BARI 2D Trial. (2015) (102)
Effect of sustaining lifestyle modifications (nonsmoking, weight reduction, physical activity, and mediterranean diet) after healing of myocardial infarction, percutaneous intervention, or coronary bypass (from the REasons for Geographic and Racial Differences in Stroke Study). (2014) (100)
Acute Antithrombotic Effect of a Front-Loaded Regimen of Clopidogrel in Patients With Atherosclerosis on Aspirin (2000) (98)
Time Course of LDL Cholesterol Exposure and Cardiovascular Disease Event Risk. (2020) (91)
Therapeutic Anticoagulation in Critically Ill Patients with Covid-19-Preliminary Report (2021) (88)
Compliance With Guideline-Directed Medical Therapy in Contemporary Coronary Revascularization Trials. (2018) (85)
Treatment disparities in the care of patients with and without diabetes presenting with non-ST-segment elevation acute coronary syndromes. (2006) (85)
Surgical Versus Percutaneous Coronary Revascularization in Patients With Diabetes and Acute Coronary Syndromes. (2017) (84)
Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization. (2018) (83)
Transcatheter aortic valve implantation in patients with bicuspid aortic valve: A patient level multi-center analysis. (2014) (83)
Cardiometabolic-Based Chronic Disease, Adiposity and Dysglycemia Drivers: JACC State-of-the-Art Review. (2020) (82)
Sex Differences in High-Intensity Statin Use Following Myocardial Infarction in the United States. (2018) (82)
NSAIDs are associated with lower depression scores in patients with osteoarthritis. (2013) (82)
Adherence to Statin Therapy Among US Adults Between 2007 and 2014 (2019) (80)
Effect of treatment for 12 weeks with rilapladib, a lipoprotein-associated phospholipase A2 inhibitor, on arterial inflammation as assessed with 18F-fluorodeoxyglucose-positron emission tomography imaging. (2014) (79)
Serum cystatin C and increased coronary heart disease prevalence in US adults without chronic kidney disease. (2008) (78)
Effect of Fibrinogen Concentrate vs Cryoprecipitate on Blood Component Transfusion After Cardiac Surgery: The FIBRES Randomized Clinical Trial. (2019) (78)
Targeting preschool children to promote cardiovascular health: cluster randomized trial. (2013) (73)
Impact of female sex on death and bleeding after fibrinolytic treatment of myocardial infarction in GUSTO V. (2007) (73)
Trends in the prevalence, awareness, treatment and control of high low density lipoprotein-cholesterol among United States adults from 1999-2000 through 2009-2010. (2013) (72)
Cardiovascular safety of oral semaglutide in patients with type 2 diabetes: Rationale, design and patient baseline characteristics for the PIONEER 6 trial (2018) (71)
Glucose-lowering drugs or strategies, atherosclerotic cardiovascular events, and heart failure in people with or at risk of type 2 diabetes: an updated systematic review and meta-analysis of randomised cardiovascular outcome trials. (2020) (71)
Trends in Use of High-Intensity Statin Therapy After Myocardial Infarction, 2011 to 2014. (2017) (70)
Use of clinically based troponin underestimates the cardiac injury in non-cardiac surgery: a single-centre cohort study in 51,701 consecutive patients (2012) (70)
Associations between routine coronary computed tomographic angiography and reduced unnecessary hospital admissions, length of stay, recidivism rates, and invasive coronary angiography in the emergency department triage of chest pain. (2013) (69)
Relationship of serum inflammatory biomarkers with plaque inflammation assessed by FDG PET/CT: the dal-PLAQUE study. (2013) (68)
Cardiovascular and cerebrovascular events among patients receiving omalizumab: Results from EXCELS, a prospective cohort study in moderate to severe asthma (2017) (67)
Multidisciplinary Heart Failure Clinics Are Associated With Lower Heart Failure Hospitalization and Mortality: Systematic Review and Meta-analysis. (2017) (66)
The effect of BMS-582949, a P38 mitogen-activated protein kinase (P38 MAPK) inhibitor on arterial inflammation: a multicenter FDG-PET trial. (2015) (66)
The relationships between cardiovascular disease and diabetes: focus on pathogenesis. (2014) (66)
Association of Myocardial Enzyme Elevation and Survival Following Coronary Artery Bypass Graft Surgery (2012) (65)
Cardiovascular magnetic resonance parameters of atherosclerotic plaque burden improve discrimination of prior major adverse cardiovascular events (2009) (65)
Effect of nitric oxide synthase inhibition on haemodynamics and outcome of patients with persistent cardiogenic shock complicating acute myocardial infarction: a phase II dose-ranging study. (2007) (65)
Prognostic significance of postprocedural sustained ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention (from the HORIZONS-AMI Trial). (2012) (64)
Prevalence and risk factors of carotid vessel wall inflammation in coronary artery disease patients: FDG-PET and CT imaging study. (2011) (62)
Real-world risk of cardiovascular outcomes associated with hypertriglyceridaemia among individuals with atherosclerotic cardiovascular disease and potential eligibility for emerging therapies. (2019) (62)
Effect of CYP2C19 Genotype on Ischemic Outcomes During Oral P2Y12 Inhibitor Therapy: A Meta-Analysis. (2021) (62)
Impact of noninsulin-dependent type 2 diabetes on carotid wall 18F-fluorodeoxyglucose positron emission tomography uptake. (2012) (62)
Clopidogrel Pharmacogenetics: State-of-the-Art Review and the TAILOR-PCI Study (2019) (61)
Rationale and design of dal-PLAQUE: a study assessing efficacy and safety of dalcetrapib on progression or regression of atherosclerosis using magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography/computed tomography. (2011) (60)
Statins and contrast-induced acute kidney injury with coronary angiography. (2014) (59)
New insights into the link between cardiovascular disease and depression (2007) (59)
The complementary roles of dynamic contrast-enhanced MRI and 18F-fluorodeoxyglucose PET/CT for imaging of carotid atherosclerosis (2013) (59)
Modulating peroxisome proliferator-activated receptors for therapeutic benefit? Biology, clinical experience, and future prospects. (2012) (59)
Assessing Patient-Reported Outcomes and Preferences for Same-Day Discharge After Percutaneous Coronary Intervention: Results From a Pilot Randomized, Controlled Trial (2013) (59)
Meta‐analysis: colonoscopic post‐polypectomy bleeding in patients on continued clopidogrel therapy (2013) (57)
Eosinophiluria in atheroembolic renal disease. (1991) (56)
Comparative efficacy of coronary artery bypass surgery vs. percutaneous coronary intervention in patients with diabetes and multivessel coronary artery disease with or without chronic kidney disease. (2016) (56)
Effect of P2Y12 Inhibitors on Survival Free of Organ Support Among Non-Critically Ill Hospitalized Patients With COVID-19: A Randomized Clinical Trial. (2022) (56)
Dipeptidyl peptidase-4 inhibitors and the risk of heart failure: a systematic review and meta-analysis. (2017) (55)
Redevelopment and validation of the SYNTAX score II to individualise decision making between percutaneous and surgical revascularisation in patients with complex coronary artery disease: secondary analysis of the multicentre randomised controlled SYNTAXES trial with external cohort validation (2020) (53)
Medical Treatment and Revascularization Options in Patients With Type 2 Diabetes and Coronary Disease. (2016) (52)
Are patients with inflammatory bowel disease at increased risk of coronary artery disease? (2012) (52)
Association of Adverse Childhood Experiences With Cardiovascular Disease Later in Life: A Review. (2020) (52)
Statin Underuse and Low Prevalence of LDL-C Control Among U.S. Adults at High Risk of Coronary Heart Disease (2014) (51)
Guideline-indicated treatments and diagnostics, GRACE risk score, and survival for non-ST elevation myocardial infarction (2018) (50)
Promotion of cardiovascular health in preschool children: 36-month cohort follow-up. (2013) (50)
Influence of coronary heart disease on morbidity and mortality after lower extremity revascularization surgery: a population-based study in Olmsted County, Minnesota (1970-1987). (1994) (49)
A phase 2 randomized, double-blind, placebo-controlled study of the effect of VIA-2291, a 5-lipoxygenase inhibitor, on vascular inflammation in patients after an acute coronary syndrome. (2015) (49)
Effect of exercise treadmill testing and stress imaging on the triage of patients with chest pain: CHEER substudy. (2005) (49)
Outcomes and Care of Patients With Acute Heart Failure Syndromes and Cardiac Troponin Elevation (2013) (48)
Risk for recurrent coronary heart disease and all-cause mortality among individuals with chronic kidney disease compared with diabetes mellitus, metabolic syndrome, and cigarette smokers. (2013) (48)
Cardiovascular safety of biologic therapies for the treatment of RA (2012) (47)
Next Steps in Primary Prevention of Coronary Heart Disease: Rationale for and Design of the ECAD Trial. (2015) (46)
Dual Antiplatelet Therapy Versus Aspirin Monotherapy in Diabetics With Multivessel Disease Undergoing CABG: FREEDOM Insights. (2017) (46)
Improving the Appropriate Use of Transthoracic Echocardiography: The Echo WISELY Trial. (2017) (46)
Arterial and fat tissue inflammation are highly correlated : a prospective 18F-FDG PET/CT study (2014) (46)
Crushed clopidogrel administered via nasogastric tube has faster and greater absorption than oral whole tablets. (2009) (45)
Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trial (2020) (45)
Management of coronary risk factors by registered nurses versus usual care in patients with unstable angina pectoris (a chest pain evaluation in the emergency room [CHEER] substudy). (2000) (45)
The appropriateness of coronary investigation in myocardial injury and type 2 myocardial infarction (ACT‐2): A randomized trial design (2019) (43)
Overall and Cause-Specific Mortality in Randomized Clinical Trials Comparing Percutaneous Interventions With Coronary Bypass Surgery: A Meta-analysis. (2020) (43)
Effect of Intensive Versus Standard Blood Glucose Control in Patients With Type 2 Diabetes Mellitus in Different Regions of the World: Systematic Review and Meta-analysis of Randomized Controlled Trials (2015) (42)
Cardiometabolic-Based Chronic Disease, Addressing Knowledge and Clinical Practice Gaps: JACC State-of-the-Art Review. (2020) (41)
Comparison of direct stenting with conventional stent implantation in acute myocardial infarction. (2011) (41)
SYNTAX Score in Patients With Diabetes Undergoing Coronary Revascularization in the FREEDOM Trial. (2018) (41)
Clinical Risk Stratification in the Emergency Department Predicts Long-Term Cardiovascular Outcomes in a Population-Based Cohort Presenting With Acute Chest Pain: Primary Results of the Olmsted County Chest Pain Study (2009) (41)
The Future REvascularization Evaluation in patients with Diabetes mellitus: optimal management of Multivessel disease (FREEDOM) trial: clinical and angiographic profile at study entry. (2012) (41)
Comparison of Dual-antiplatelet Therapy to Mono-antiplatelet Therapy After Transcatheter Aortic Valve Implantation: Systematic Review and Meta-analysis. (2015) (40)
Association Between Physician Follow-Up and Outcomes of Care After Chest Pain Assessment in High-Risk Patients (2013) (39)
Genotype-based clinical trials in cardiovascular disease (2015) (39)
Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease: A Randomized Clinical Trial. (2020) (39)
Predictors of low clopidogrel adherence following percutaneous coronary intervention. (2011) (38)
Causes of death and re‐hospitalization in cardiogenic shock (2007) (37)
High‐dose influenza vaccine to reduce clinical outcomes in high‐risk cardiovascular patients: Rationale and design of the INVESTED trial☆☆ (2018) (37)
Atherosclerotic Risk and Statin Use Among Patients With Peripheral Artery Disease. (2020) (36)
Long-Term Survival After Surgical or Percutaneous Revascularization in Patients With Diabetes and Multivessel Coronary Disease. (2020) (36)
Relationship Between ST-Segment Recovery and Clinical Outcomes After Primary Percutaneous Coronary Intervention: The HORIZONS-AMI ECG Substudy Report (2013) (36)
Serum Inflammatory Biomarkers and Plaque Inflammation Assessed by 18 F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the dal-PLAQUE Study (2013) (34)
Diabetes Mellitus and Acute Coronary Syndrome: Lessons From Randomized Clinical Trials (2012) (33)
Prognostic Value of Late Gadolinium Enhancement for the Prediction of Cardiovascular Outcomes in Dilated Cardiomyopathy (2020) (33)
Stroke After Coronary Artery Bypass Grafting and Percutaneous Coronary Intervention: Incidence, Pathogenesis, and Outcomes (2019) (33)
C-reactive protein predicts long-term mortality independently of low-density lipoprotein cholesterol in patients undergoing percutaneous coronary intervention. (2009) (33)
Complementary prognostic utility of myocardial blush grade and ST-segment resolution after primary percutaneous coronary intervention: analysis from the HORIZONS-AMI trial. (2013) (33)
Therapeutic Arthritis Research and Gastrointestinal Event Trial of lumiracoxib – study design and patient demographics (2004) (32)
Myocardial Revascularization Trials: Beyond the Printed Word (2018) (32)
An Internet-Based Counseling Intervention With Email Reminders that Promotes Self-Care in Adults With Chronic Heart Failure: Randomized Controlled Trial Protocol (2014) (31)
PCSK9 Variants, Low-Density Lipoprotein Cholesterol, and Neurocognitive Impairment: Reasons for Geographic and Racial Differences in Stroke Study (REGARDS) (2017) (31)
Declines in coronary heart disease incidence and mortality among middle-aged adults with and without diabetes. (2014) (30)
Emerging anti-inflammatory drugs for atherosclerosis (2013) (30)
Therapeutic Anticoagulation in Non-Critically Ill Patients with Covid-19 (2021) (30)
Trends in Recurrent Coronary Heart Disease Following Myocardial Infarction Among US Women and Men Between 2008 and 2017. (2020) (29)
Correlation between index electrocardiographic patterns and pre‐intervention angiographic findings: Insights from the HORIZONS‐AMI trial (2012) (28)
Impact of Chronic Kidney Disease on Outcomes of Myocardial Revascularization in Patients With Diabetes. (2019) (28)
LDL cholesterol response and statin adherence among high-risk patients initiating treatment. (2016) (27)
Review: Adverse cardiovascular effects of NSAIDs: driven by blood pressure, or edema? (2008) (27)
Elevated homocysteine levels in patients with end-stage renal disease. (2005) (27)
Ability of low antihypertensive medication adherence to predict statin discontinuation and low statin adherence in patients initiating treatment after a coronary event. (2014) (27)
Effect of Anti-inflammatory Treatment on Depression , Depressive Symptoms , and Adverse Effects (2014) (26)
Clinical risk stratification correlates with the angiographic extent of coronary artery disease in unstable angina. (2001) (26)
Thrombolytic Agents: The Science of the Art of Choosing the Better Treatment (1994) (26)
Authors' self-declared financial conflicts of interest do not impact the results of major cardiovascular trials. (2013) (25)
Cardiovascular Risk Factor Management Performance in Canada and the United States: A Systematic Review. (2017) (25)
Association between troponin I levels and mortality in stable hemodialysis patients. (2003) (25)
The role of primary care physician and cardiologist follow-up for low-risk patients with chest pain after emergency department assessment. (2014) (24)
Association Between Adherence to Fractional Flow Reserve Treatment Thresholds and Major Adverse Cardiac Events in Patients With Coronary Artery Disease. (2020) (24)
Trends in the Use of Nonstatin Lipid-Lowering Therapy Among Patients With Coronary Heart Disease: A Retrospective Cohort Study in the Medicare Population 2007 to 2011. (2015) (24)
Eight‐year follow‐up of the Clopidogrel After Surgery for Coronary Artery Disease (CASCADE) trial (2018) (23)
Cardiovascular effects of selective COX-2 inhibition: is there a class effect? The International COX-2 Study Group. (2006) (23)
Long-term cardiovascular outcomes in patients with angina pectoris presenting with bundle branch block. (2011) (23)
Potent arterial antithrombotic effect of direct factor-Xa inhibition with ZK-807834 administered to coronary artery disease patients (2007) (22)
Anticoagulation in Patients With COVID-19 (2022) (22)
Outcome of patients discharged from a coronary care unit with a diagnosis of "chest pain not yet diagnosed". (1996) (21)
Outcomes in patients with chest pain evaluated in a chest pain unit: the chest pain evaluation in the emergency room study cohort. (2011) (20)
Low-Density Lipoprotein Cholesterol and Adverse Cardiovascular Events After Percutaneous Coronary Intervention. (2020) (19)
Predictors of stroke associated with coronary artery bypass grafting in patients with diabetes mellitus and multivessel coronary artery disease. (2015) (19)
Rationale and design of the Canadian Outcomes Registry Late After Tetralogy of Fallot Repair: the CORRELATE study. (2014) (19)
Diminished Benefits of Drug-Eluting Stents versus Bare Metal Stents in Patients with Severe Renal Insufficiency (2009) (19)
Rapid complete reversal of systemic hypoperfusion after intra-aortic balloon pump counterpulsation and survival in cardiogenic shock complicating an acute myocardial infarction. (2011) (19)
Targeting Inflammation in the Prevention and Treatment of Type 2 Diabetes: Insights From CANTOS. (2018) (18)
Effectiveness of Interventions Aimed at Increasing Statin-Prescribing Rates in Primary Cardiovascular Disease Prevention: A Systematic Review of Randomized Clinical Trials. (2019) (18)
Diabetes and aspirin: beware of underpowered negative trials (2009) (18)
Right ventricular fibrosis is associated with cardiac remodelling after pulmonary valve replacement (2018) (18)
Willingness to be Reinitiated on a Statin (from the REasons for Geographic and Racial Differences in Stroke Study). (2018) (17)
Design and methods of the Echo WISELY (Will Inappropriate Scenarios for Echocardiography Lessen SignificantlY) study: An investigator-blinded randomized controlled trial of education and feedback intervention to reduce inappropriate echocardiograms. (2015) (17)
Why NOBLE and EXCEL Are Consistent With Each Other and With Previous Trials. (2017) (16)
Diabetes is an independent predictor of right ventricular dysfunction post ST-elevation myocardial infarction (2016) (16)
Influence of LDL-Cholesterol Lowering on Cardiovascular Outcomes in Patients With Diabetes Mellitus Undergoing Coronary Revascularization. (2020) (16)
Sex Differences in Incident and Recurrent Coronary Events and All-Cause Mortality. (2020) (16)
The Role of SGLT-2 Inhibitors as Part of Optimal Medical Therapy in Improving Cardiovascular Outcomes in Patients with Diabetes and Coronary Artery Disease (2017) (16)
Association between sepsis survivorship and long-term cardiovascular outcomes in adults: a systematic review and meta-analysis (2021) (16)
Individualizing Revascularization Strategy for Diabetic Patients With Multivessel Coronary Disease. (2019) (16)
Does influenza vaccination influence cardiovascular complications? (2015) (15)
Relation between the degree of procedural anticoagulation and complications after coronary stent implantation. (2003) (15)
Acute coronary syndromes and diabetes mellitus: a winning ticket for prasugrel. (2008) (15)
An early revascularization strategy is associated with a survival benefit for diabetic patients in cardiogenic shock after acute myocardial infarction (2006) (15)
Age and sex-specific associations of anthropometric measures of adiposity with blood pressure and hypertension in India: a cross-sectional study (2016) (15)
Protocol for a phase III, non-inferiority, randomised comparison of a new fibrinogen concentrate versus cryoprecipitate for treating acquired hypofibrinogenaemia in bleeding cardiac surgical patients: the FIBRES trial (2018) (14)
Historical Neighborhood Redlining and Contemporary Cardiometabolic Risk. (2022) (14)
Awareness, Treatment, and Control of LDL Cholesterol Are Lower Among U.S. Adults With Undiagnosed Diabetes Versus Diagnosed Diabetes (2013) (13)
Readmission rates following heart failure: a scoping review of sex and gender based considerations (2020) (13)
Characteristics and Cardiovascular Disease Event Rates among African Americans and Whites Who Meet the Further Cardiovascular Outcomes Research with PCSK9 Inhibition in Subjects with Elevated Risk (FOURIER) Trial Inclusion Criteria (2019) (13)
Improving the clinical examination for a low ankle-brachial index (2002) (12)
Urgent Revascularization Strategies in Patients With Diabetes Mellitus and Acute Coronary Syndrome. (2019) (12)
Long-term outcomes in non-diabetic patients with metabolic syndrome undergoing revascularization for multi-vessel coronary artery disease. (2008) (12)
Effect of Anti-inflammatory Treatment on Depression , Depressive Symptoms , and Adverse Effects A Systematic Review andMeta-analysis of Randomized Clinical Trials (2014) (11)
Preoperative Intraaortic Balloon Pump Improves Early Outcomes Following High-Risk Coronary Artery Bypass Graft Surgery: A Meta-Analysis of Randomized Trials and Prospective Study Design. (2018) (11)
Meta-analysis of small trials: proceed with caution. (2008) (11)
Comparison of Drug-Eluting Stents With Bare-Metal Stents for PCI of Saphenous Vein Graft Lesions: Systematic Review and Meta-Analysis. (2016) (11)
Biomarkers after risk stratification in acute chest pain (from the BRIC Study). (2013) (11)
Cardiovascular risk surveillance to develop a nationwide health promotion strategy: the grenada heart project. (2012) (10)
Chagas disease as a mechanistic model for testing a novel hypothesis. (2008) (10)
Old Drugs for New Indications in Cardiovascular Medicine (2018) (10)
A Comparison of the Blood Pressure Changes of Lumiracoxib With Those of Ibuprofen and Naproxen (2008) (10)
Chronic kidney disease as a risk factor for acute coronary syndromes in patients presenting to the emergency room with chest pain. (2012) (9)
Automated E-Counseling for Chronic Heart Failure: CHF-CePPORT Trial. (2021) (9)
Does acetylsalicylic acid or warfarin affect the accuracy of fecal occult blood tests? (2013) (9)
Platelet Reactivity in Patients With Acute Coronary Syndromes Awaiting Surgical Revascularization. (2021) (9)
Prevention of Heart Failure With SGLT-2 Inhibition: Insights From CVD-REAL. (2018) (9)
Grenada Heart Project-Community Health ActioN to EncouraGe healthy BEhaviors (GHP-CHANGE): A randomized control peer group-based lifestyle intervention. (2019) (9)
Type 1 Diabetes, Coronary Disease Complexity, and Optimal Revascularization Strategy. (2017) (9)
The Role of Coronary Artery Bypass Surgery Versus Percutaneous Intervention in Patients with Diabetes and Coronary Artery Disease. (2019) (9)
International survey of patients undergoing percutaneous coronary intervention and their attitudes toward pharmacogenetic testing (2019) (9)
Statin Use Following Hospitalization Among Medicare Beneficiaries With a Secondary Discharge Diagnosis of Acute Myocardial Infarction (2015) (9)
Maximizing benefits of therapies in acute myocardial infarction. (1993) (9)
Chelation Therapy as a Cardiovascular Therapeutic Strategy: the Rationale and the Data in Review (2017) (9)
Meta-Analysis of Studies Comparing Dual- Versus Mono-Antiplatelet Therapy Following Transcatheter Aortic Valve Implantation. (2018) (9)
Faster publication isn't always better (2007) (9)
Diabetes and multivessel disease: coronary artery bypass grafting remains king (2018) (8)
Rationale and Design of the Comparison of Outcomes and Access to Care for Heart Failure (COACH) Trial: A Stepped Wedge Cluster Randomized Trial. (2021) (8)
Cost-effectiveness of on-pump and off-pump coronary artery bypass grafting for patients with coronary artery disease: Results from the MASS III trial. (2018) (8)
Is measuring C-reactive protein useful for guiding treatment in women > or = 60 years and men > or = 50 years of age? (2009) (8)
ABCD‐GENE Score and Clinical Outcomes Following Percutaneous Coronary Intervention: Insights from the TAILOR‐PCI Trial (2022) (8)
Usefulness of diabetes mellitus to predict long-term outcomes in patients with unstable angina pectoris. (2009) (8)
Rapid Exclusion of COVID Infection With the Artificial Intelligence Electrocardiogram (2021) (8)
Incidence, determinants and impact of acute kidney injury in patients with diabetes mellitus and multivessel disease undergoing coronary revascularization: Results from the FREEDOM trial. (2019) (8)
Trial of an Intervention to Improve Acute Heart Failure Outcomes. (2022) (8)
Medical Expenditures Among Medicare Beneficiaries with Statin-Associated Adverse Effects Following Myocardial Infarction (2018) (7)
General Cardiology Perspective: Decision Making Regarding Revascularization of Patients With Type 2 Diabetes Mellitus and Cardiovascular Disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial (2010) (7)
Early coronary angiography improves long-term survival in unstable angina. (2001) (7)
Risk for ischemic stroke and coronary heart disease associated with migraine and migraine medication among older adults (2021) (7)
Coronary Revascularization of Patients With Diabetes Mellitus in the Setting of Acute Coronary Syndromes. (2019) (7)
Rationale and design of the TAILOR-PCI digital study: Transitioning a randomized controlled trial to a digital registry (2020) (7)
Balancing cardiovascular and gastrointestinal risks in patients with osteoarthritis receiving nonsteroidal anti‑inflammatory drugs. A summary of guidelines from an international expert group. (2016) (7)
Secular changes in rates of coronary heart disease, fatal coronary heart disease, and out-of-hospital fatal coronary heart disease. (2014) (7)
Design of the Magnetic Resonance Imaging Evaluation of Mineralocorticoid Receptor Antagonism in Diabetic Atherosclerosis (MAGMA) Trial (2017) (7)
Comparative associations between anthropometric and bioelectric impedance analysis derived adiposity measures with blood pressure and hypertension in India: a cross-sectional analysis (2017) (7)
Early invasive coronary angiography and acute ischaemic heart failure outcomes (2021) (7)
Clustering of metabolic abnormalities among obese patients and mortality after percutaneous coronary intervention. (2011) (7)
Relation of high-density lipoprotein cholesterol to mortality after percutaneous coronary interventions in patients with low-density lipoprotein <70 mg/dl. (2009) (7)
Cardiology Patient Page: coronary artery revascularization in patients with diabetes mellitus. (2014) (7)
Lumiracoxib, a highly selective COX-2 inhibitor (2005) (6)
Recent Insights into Pharmacologic Cardiovascular Risk Reduction in Type 2 Diabetes Mellitus (2017) (6)
Thrombolysis In Myocardial Infarction (TIMI) risk score and mortality in patients with advanced chronic kidney disease and on dialysis. (2009) (6)
Left ventricular hypertrophy by electrocardiography and echocardiography in the African American Study of Kidney Disease Cohort Study. (2012) (6)
Imaging outcomes in cardiovascular clinical trials (2009) (6)
Long-Term Survival Following Multivessel Revascularization in Patients With Diabetes The (2019) (6)
Noninvasive cardiovascular imaging in rheumatoid arthritis: current modalities and the emerging role of magnetic resonance and positron emission tomography imaging. (2012) (6)
The Management of Acute Chest Pain: What Lies Beyond the Emergency Department Doors? (2016) (6)
Titration to High-Intensity Statin Therapy Following Acute Myocardial Infarction in Patients With and Without Diabetes Mellitus (2018) (6)
Residual risk for coronary heart disease events and mortality despite intensive medical management after myocardial infarction. (2020) (5)
Implications of the ISCHEMIA trial on the practice of surgical myocardial revascularization. (2020) (5)
Usefulness of ECG criteria to rule out left ventricular hypertrophy in older individuals with true left bundle branch block: an observational study (2021) (5)
Aspirin Use Is Associated With an Improved Long‐Term Survival in an Unselected Population Presenting With Unstable Angina (2010) (5)
Biomarkers in the emergency workup of chest pain: Uses, limitations, and future (2013) (5)
Comparison of Troponin Elevation, Prior Myocardial Infarction, and Chest Pain in Acute Ischemic Heart Failure (2020) (5)
CRP has little incremental value over traditional cardiovascular risk factors in risk stratification (2007) (5)
Time to welcome the elderly into clinical trials (2008) (5)
Sunday, 26 August 2012 (2012) (5)
Comparison of Readmission and Death Among Patients With Cardiac Disease in Northern vs Southern Ontario. (2019) (5)
Abstract 4323: Mortality Associated With Proton Pump Inhibitors Following Percutaneous Coronary Interventions With Drug Eluting Stents (2009) (5)
Association Between Transthoracic Echocardiography Appropriateness and Echocardiographic Findings (2019) (5)
Weighing Coronary Revascularization Options in Patients With Type 2 Diabetes Mellitus. (2020) (5)
187 Influenza Vaccination and Reduction of Cardiovascular Events-A Systematic Review and Meta-Analysis (2012) (4)
Colchicine and the combination of rivaroxaban and aspirin in patients hospitalised with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial (2022) (4)
Meta-analysis of small trials: proceed with caution (2007) (4)
Hypercholesterolemia is associated with visual field alterations detectable with computerized perimetry. (2007) (4)
Impact of Age and Sex on Cardiovascular Magnetic Resonance Measurements: After Tetralogy of Fallot Repair. (2020) (4)
The Anti-Coronavirus Therapies (ACT) Trials: Design, Baseline Characteristics, and Challenges (2022) (4)
In ﬂ ammation, Immunity, and Infection in Atherothrombosis (2018) (4)
Machine Learning Approach to Classify Cardiovascular Disease in Patients With Nonalcoholic Fatty Liver Disease in the UK Biobank Cohort (2021) (4)
Temporal Trends and Drivers of Heart Team Utilization in Transcatheter Aortic Valve Replacement: A Population‐Based Study in Ontario, Canada (2021) (4)
Impact of the COVID-19 Pandemic on Non-COVID-19 Clinical Trials (2022) (4)
Clinical applicability and diagnostic performance of electrocardiographic criteria for left ventricular hypertrophy diagnosis in older adults (2021) (4)
PCSK9 loss-of-function variants and Lp(a) phenotypes among black US adults[S] (2019) (4)
Impact of Noninsulin-Dependent Type 2 Diabetes on Carotid Wall 18 F-Fluorodeoxyglucose (2012) (3)
Revascularization Strategies for the Treatment of Multivessel Coronary Artery Disease in Patients With Diabetes Mellitus. (2020) (3)
Non-steroidal anti-inflammatory drugs and the heart (2010) (3)
Population-Based Recalibration of the Framingham Risk Score and Pooled Cohort Equations. (2022) (3)
Relation of Post-Coronary Artery Bypass Graft Creatine Kinase-MB Elevations and New Q Waves With Long-Term Cardiovascular Death in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease. (2016) (3)
The Trial to Assess Chelation Therapy 2 (TACT2): Rationale and Design. (2022) (3)
External Validation of the FREEDOM Score for Individualized Decision Making Between CABG and PCI. (2022) (3)
COVID‐19: a pandemic experience that illuminates potential reforms to health research (2020) (3)
Chronic Kidney Disease as a Coronary Heart Disease Risk Equivalent (2010) (3)
Hypotheses, rationale, design, and methods for prognostic evaluation of a randomized comparison between patients with coronary artery disease associated with ischemic cardiomyopathy who undergo medical or surgical treatment: MASS-VI (HF) (2020) (3)
The conundrum of the treatment for left main coronary disease. (2020) (3)
Cardiology Training in Brazil and Developed Countries: Some Ideas for Improvement (2019) (3)
A Unique Multi- and Interdisciplinary Cardiology-Renal-Endocrine Clinic: A Description and Assessment of Outcomes (2022) (3)
Optimal treatment of the diabetic patient with multivessel disease (2008) (3)
Statins improve visual field alterations related to hypercholesterolemia. (2010) (3)
Review: diabetes is not a coronary disease equivalent (2009) (3)
Coronary artery bypass grafting versus medical therapy in patients with stable coronary artery disease: An individual patient data pooled meta-analysis of randomized trials. (2022) (2)
Anticoagulation Strategies in Non-Critically Ill Patients Hospitalized with COVID-19: A Randomized Clinical Trial (2023) (2)
Periprocedural Myocardial Enzyme Elevation: Prognostic Implications for Current Practice (2012) (2)
Association of post‐vaccination adverse reactions after influenza vaccine with mortality and cardiopulmonary outcomes in patients with high‐risk cardiovascular disease: the INVESTED trial (2022) (2)
CABG Versus PCI for Complex Coronary Disease: Time to Close the Books. (2017) (2)
Outcomes with revascularization and medical therapy in patients with coronary disease and chronic kidney disease: A meta-analysis. (2022) (2)
The incremental value of troponin‐I testing in patients with intermediate risk unstable angina (2004) (2)
AHA Scientific Statement Testing of Low-Risk Patients Presenting to the Emergency Department With Chest Pain A Scientific Statement From the American Heart Association (2010) (2)
Prognostic Significance of Post-CABG Enzyme Elevations. (2017) (2)
Diagnosis & treatment of chronic arterial insufficiency of the lower extremities (1996) (2)
Intensity of Guideline-Directed Medical Therapy for Coronary Heart Disease and Ischemic Heart Failure Outcomes. (2020) (2)
Impact of diabetes on coronary remodeling in patients with acute coronary syndromes: An intravascular ultrasound study (2003) (2)
COMPARISON BETWEEN CARDIOVASCULAR TRIAL OUTCOMES AND TREATMENT EFFECTS USING CLINICAL ENDPOINT COMMITTEE ADJUDICATION VERSUS ROUTINE HEALTH DATA: A SYSTEMATIC REVIEW (2019) (2)
Cardiorenal outcomes in eligible patients referred for bariatric surgery (2021) (2)
Plenary Oral Abstract Session (2021) (2)
Risk for recurrent cardiovascular disease events among patients with diabetes and chronic kidney disease (2021) (2)
A Web-Based Health Application to Translate Nutrition Therapy for Cardiovascular Risk Reduction in Primary Care (PortfolioDiet.app): Quality Improvement and Usability Testing Study (2022) (2)
New insights into the link between cardiovascular disease and depression. Commentary (2008) (2)
Point of care CYP2C19 genotyping after percutaneous coronary intervention (2022) (2)
Surgical vs percutaneous coronary revascularization in patients with diabetes following an acute coronary syndrome (2019) (2)
The Associations Between Direct and Delayed Critical Care Unit Admission with Mortality and Readmissions Among Patients with Heart Failure. (2020) (2)
Colchicine and aspirin in community patients with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial (2022) (2)
The Ongoing Care Gap for Women Enrolled in ACS Randomized Trials. (2019) (2)
Letter by Toeg et al regarding article, "Outcomes with coronary artery bypass graft surgery versus percutaneous coronary intervention for patients with diabetes mellitus: can newer generation drug-eluting stents bridge the gap?". (2014) (2)
Cardiovascular disease in diabetics: pharmacology and revascularization. (2004) (2)
Lifestyle Interventions in Diabetes and Coronary Disease: A Timely Reminder. (2019) (2)
Risk profiling patients for selective use of drug-eluting stents is warranted (2007) (2)
Association between time to therapeutic INR and length of stay following mechanical heart valve surgery (2021) (2)
PCSK9 VARIANTS AND NEUROCOGNITIVE IMPAIRMENT: DATA FROM THE REASONS FRO GEOGRAPHIC AND RACIAL DIFFERENCES IN STROKE (REGARDS) STUDY (2017) (2)
THE IMPACT OF CONFLICTS OF INTEREST ON ADJUDICATION AND OUTCOMES IN CARDIOVASCULAR CLINICAL TRIALS (2010) (2)
Association of Incident Cardiovascular Disease With Time Course and Cumulative Exposure to Multiple Risk Factors. (2023) (2)
Revascularization for patients with diabetes mellitus and stable ischemic heart disease: an update (2017) (2)
Optimal approaches to diabetic patients with multivessel disease. (2015) (2)
The Projected Impact of Population-Wide Achievement of LDL Cholesterol <70 mg/dL on the Number of Recurrent Events Among US Adults with ASCVD (2021) (1)
The PROSPECT of changing our approach to acute coronary syndromes. (2012) (1)
Society Guidelines Canadian Cardiovascular Society Guidelines for the Diagnosis and Management of Stable Ischemic Heart Disease (2014) (1)
Food as Medicine for Secondary Prevention of Cardiovascular Events Following an Acute Coronary Syndrome (2018) (1)
Translating Scientific Evidence Into Clinical Practice: Closing the Loop. (2019) (1)
PROTOTYPICAL TRAJECTORIES OF PATIENT ENGAGEMENT WITH AN E-COUNSELLING PLATFORM TO PROMOTE SELF-CARE IN HEART FAILURE (2015) (1)
Abstract 15587: Trends in High Ldl-Cholesterol Prevalence, Awareness, Treatment and Control Among Us Adults (2012) (1)
Reply: is it not timely to consider how to balance cardiorenometabolic benefits and risks of statins? (2014) (1)
Abstract 1709: Undiagnosed Diabetic Patients Undergoing Elective Percutaneous Coronary Interventions Have a High Rate of Mortality (2009) (1)
The Impact of COVID-19 Research on the Development of Scalable Frameworks for Efficient Clinical Trials in Cardiovascular Medicine (2023) (1)
Abstract 13315: Long-term Risk of Cardiovascular Events Following Hospitalization for Sepsis: A Systematic Review and Meta-analysis (2020) (1)
ACP Journal Club. Valsartan reduced diabetes but not CV events in patients with impaired glucose tolerance and CV risk factors. (2010) (1)
Primary prevention of atherosclerotic cardiovascular disease: bringing clinicians and patients to the starting line. (2014) (1)
Optimal cardiometabolic health and risk of heart failure in type 2 diabetes: an analysis from the Look AHEAD trial (2022) (1)
Abstract 20673: Evaluation of an Intervention to Promote Healthy Heart Habits in Preschool Children: A Cluster Randomized Trial (2010) (1)
Chronic noncommunicable diseases and COVID-19: How they both interact (2021) (1)
DUAL ANTI-PLATELET THERAPY IS NOT SUPERIOR TO ASPIRIN ALONE AFTER CORONARY ARTERY BYPASS IN DIABETIC PATIENTS WITH MULTI-VESSEL DISEASE: INSIGHTS FROM THE FREEDOM TRIAL (2016) (1)
Abstract 15687: Reasons for Statin Discontinuation With and Without a Physician’s Advice: Data From the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study (2016) (1)
The complementary roles of dynamic contrast-enhanced MRI and [supersript 18]F-fluorodeoxyglucose PET/CT for imaging of carotid atherosclerosis (2013) (1)
Gender differences in clinical outcomes after percutaneous coronary intervention in small coronary arteries (2002) (1)
Abstract P271: Sedentary Behavior and Cardiovascular Disease Risk in a Middle-income Country: The Grenada Heart Project (2012) (1)
High-sensitivity troponin < 3 ng/L ruled out acute myocardial infarction (2012) (1)
Abstract 11: Comparison of Patient Reported Angina with Provider Assigned Canadian Cardiovascular Society Angina Class Before and After Revascularization (2016) (1)
Left main revascularization: an evidence-based reconciliation. (2022) (1)
Revascularization for Advanced Coronary Artery Disease in Type 2 Diabetic Patients: Choosing Wisely Between PCI and Surgery (2017) (1)
CABG Versus PCI in Patients With Diabetes: A Meta-Analysis of Randomized Controlled Trials in the Era of Des (2013) (1)
Reply: Relevance of Indications for CABG in Evaluating the Effect of Dual Antiplatelet Therapy. (2017) (1)
Accuracy of Cardiovascular Trial Outcome Ascertainment and Treatment Effect Estimates from Routine Health Data (2021) (1)
Noninvasive atherosclerosis imaging modalities and their application to investigating cardiovascular drug effects in rheumatoid arthritis (2011) (1)
Statin Use for Primary Cardiovascular Disease Prevention is Low in Inflammatory Arthritis. (2022) (1)
326 Disparity Between Clinical Trials and Registry Outcomes: Reflections From the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI-2D) Trial (2012) (1)
Blood glucose variability: a new metric for interventional cardiology? (2015) (1)
PRE-OPERATIVE INTRA-AORTIC BALLOON PUMP (IABP) DECREASES MORTALITY AND MAJOR ADVERSE CARDIOVASCULAR AND CEREBROVASCULAR EVENTS (MACCE) IN HIGH-RISK CORONARY ARTERY BYPASS (CABG) PATIENTS (2015) (1)
Missing the Goal with the 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization. (2022) (1)
One year follow up in aortic and carotid FDG-PET/CT imaging of atherosclerotic plaque inflammation (2008) (1)
EFFECT OF INTENSIVE COMPARED WITH STANDARD BLOOD GLUCOSE CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN DIFFERENT REGIONS OF THE WORLD: SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS (2014) (1)
Faculty Opinions recommendation of Novel approaches for preventing or limiting events (Naples) II trial: impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction. (2010) (1)
Abstract 20356: Comparison of CABG versus PCI Outcomes in Diabetic, Mutivessel Coronary Artery Disease Patients With and Without Acute Coronary Syndromes (2014) (1)
Abstract 19550: Incidence, Correlates and Impact of Acute Kidney Injury in Diabetic Patients With Multivessel Disease Undergoing Coronary Revascularization: Results From the FREEDOM Trial (2016) (1)
Association between obesity and chronic kidney disease: multivariable Mendelian randomization analysis and observational data from a bariatric surgery cohort. (2023) (1)
Moving Beyond the Stent: Identifying the Percutaneous Coronary Intervention Patient With Silent Diabetes and Pre-Diabetes. (2018) (1)
High-Dose Atorvastatin Reduces Periodontal Inflammation (2013) (1)
SEX-BASED DIFFERENCES IN CLINICAL OUTCOMES AFTER PERCUTANEOUS CORONARY INTERVENTION: INSIGHTS FROM THE TAILOR-PCI TRIAL (2021) (1)
REmote moBile Outpatient mOnitoring in Transplant (Reboot) 2.0: a randomized control trial protocol. (2020) (1)
Validation of billing code combinations to identify cardiovascular magnetic resonance imaging scans in Ontario, Canada: a retrospective cohort study (2018) (1)
Personalizing Antiplatelet Therapies for Acute Coronary Syndrome (ACS) in Patients Undergoing Percutaneous Coronary Intervention (PCI): Are They Cost-effective? (2017) (1)
Meta-analysis: Atorvastatin reduces CV events and increases new-onset diabetes in patients with coronary disease (2013) (1)
Abstract MP76: Trends in Adherence to Statin Therapy Among US Adults With Health Insurance Between 2007 and 2014 (2018) (1)
Reviewers for the Journal, January-June 2016. (2016) (1)
Personalised Approaches to Improving the Effect of Anti-platelet Agents: Where Do We Stand? (2019) (1)
Abstract 13175: Outcomes of Heart Failure (HF) Patients Admitted to the Intensive Care Unit (ICU): Impact of Early or Late ICU Admission (2016) (1)
1060-80 Female sex: A more important prognostic marker than treatment assignment or comorbid conditions among patients with acute myocardial infarction in the GUSTO V trial (2004) (1)
Diabetic multivessel disease: stenting vs. coronary artery bypass grafting. (2007) (1)
Revascularization strategies in patients with diabetes. (2013) (1)
Reply: Precision Antiplatelet Therapy for CYP2C19 Genotype Variants for Achieving Better Clinical Outcomes. (2021) (0)
P5322Oxidized phospholipids on apolipoprotein B-100 among black US adults with and without PCSK9 loss-of-function variants (2019) (0)
Identification and Management of Low Risk Patients Presenting to the Emergency Department with Chest Pain (2020) (0)
CHARACTERISTICS AND CARDIOVASCULAR DISEASE EVENT RATES AMONG AFRICAN AMERICANS WHO MEET THE FOURIER INCLUSION CRITERIA (2018) (0)
The contribution of risk factors to inflammation in carotid atherosclerotic plaques -- An FDG PET/CT study (2007) (0)
Non-steroidal anti-inflammatory drugs and cardiovascular risk: At crossroads. (2015) (0)
Chapter 42 – Diabetes and Cardiovascular Disease (2014) (0)
Factor VIII Products and Inhibitors in Severe Hemophilia A (2013) (0)
INTENSIVE MEDICAL MANAGEMENT AND OUTCOMES FOLLOWING MYOCARDIAL INFARCTION (2016) (0)
GC1QR: A NOVEL BIOMARKER ASSOCIATED WITH RISK OF CARDIOVASCULAR EVENTS (2013) (0)
Abstract 18092: Statin Use After an Acute In-Hospital Myocardial Infarction Among Medicare Beneficiaries (2013) (0)
P652Lower use of statins among patients with peripheral artery disease compared with those with coronary heart disease (2019) (0)
Abstract 18590: The Underutilization of Guideline Recommended Antihypertensive Agents is Associated with a High Prevalence of Uncontrolled Hypertension in Urban Community Dwelling Older Adults (2012) (0)
Reply (2018) (0)
Abstract 15738: The Awareness, Treatment, and Control of LDL-Cholesterol is Lower Among US Adults with Undiagnosed versus Diagnosed Diabetes (2012) (0)
Review: Vitamin E is not clearly effective for intermittent claudication (1998) (0)
Abstract 11699: Angiographic Coronary Artery Disease (CAD) and Outcomes in Acute Heart Failure (HF) (2021) (0)
Failing to ENHANCE science (2008) (0)
Abstract 20929: Risk Reduction Reporting in Cardiovascular Clinical Trials (2010) (0)
Contents (2020) (0)
DOES ST DEPRESSION HELP PREDICT CORONARY ARTERY DISEASE AFTER AN OUT-OF-HOSPITAL CARDIAC ARREST? (2017) (0)
4113Glucose lowering drugs or strategies, major adverse cardiovascular events and heart failure outcomes, and association with weight loss - meta-analysis of large cardiovascular outcome trials (2019) (0)
arthritis events among patients with rheumatoid associated risk reduction of cardiovascular Tumour necrosis factor antagonist use and Setoguchi and (2011) (0)
Abstract 16129: Low HDL is the only Major Risk Factor Independently Associated with Increased Inflammation in Diabetic Coronary Artery Disease Patients after Percutaneous Coronary Intervention as Measured by 18F-fluorodeoxyglucose Positron-Emission Tomography (2012) (0)
gSCIENCE ORIGINAL R ESEARCH Cardiovascular Risk Surveillance to Develop a Nationwide Health Promotion Strategy (2012) (0)
Strategies for Management of Stable Coronary Disease in Type 2 Diabetes Mellitus (2013) (0)
Abstract 18986: Low Density Lipoprotein Cholesterol Response and Statin Persistence among Patients with High Coronary Heart Disease Risk Initiating Treatment (2014) (0)
ADHERENCE TO ANTIHYPERTENSIVE MEDICATIONS PREDICTS STATIN DISCONTINUATION AMONG OLDER U.S. ADULTS (2013) (0)
RETRACTED: Revascularization in type II diabetes: Challenges and evidence from clinical trials (2015) (0)
Association of Polycythemia with Outcomes of Acute Coronary Syndrome (2021) (0)
P5224Improving the Appropriate Use of Transthoracic Echocardiography- The results of the Echo WISELY trial (2017) (0)
How important is screening angiography for CAS in diabetic patients awaiting transplant? A cardiologist's view (2007) (0)
Antiplatelet Therapy Post PCI: Evaluating a Personalized Medicine Approach. (2022) (0)
Editorial commentary: Imaging the aorta for inflammation: Informing practice on emerging molecular techniques. (2019) (0)
Abstract 20973: The Impact of Independent Statistical Analysis on Reported Outcomes in Cardiovascular Clinical Trials (2010) (0)
Faculty Opinions recommendation of Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. (2007) (0)
Atherosclerosis inflammation imaging with PET/CT is highly reproducible in the carotid arteries and aorta (2007) (0)
Stress testing and troponin in unstable coronary syndromes: the status trial-clinical outcomes and resource use. (2006) (0)
Dual Antiplatelet Therapy Versus Aspirin Monotherapy in Diabetics With Multivessel Disease Undergoing CABG (2016) (0)
Association of baseline and longitudinal changes in cardiometabolic health with risk of heart failure among adults with type 2 diabetes: an analysis from the Look AHEAD trial (2022) (0)
Protocol An Internet-Based Counseling Intervention With Email Reminders that Promotes Self-Care in Adults With Chronic Heart Failure : Randomized Controlled Trial Protocol (2016) (0)
Screening for CAD in asymptomatic patients with type 2 diabetes did not reduce risk for cardiac events (2009) (0)
DUAL VERSUS MONO-ANTIPLATELET THERAPY POST-TRANSCATHETER AORTIC VALVE IMPLANTATION: A META-ANALYSIS OF 30-DAY OUTCOMES (2014) (0)
Predicting left main stenosis in stable ischemic heart disease using logistic regression and boosted trees. (2022) (0)
The Reply. (2015) (0)
THE SELECTION OF HARD CLINICAL ENDPOINTS VERSUS SURROGATE ENDPOINTS AS THE PRIMARY OUTCOME MEASURE IN MAJOR CARDIOVASCULAR CLINICAL TRIALS IS NOT INFLUENCED BY THE SOURCE OF FUNDING (2010) (0)
Abstract 21055: Baseline Cardiovascular Magnetic Resonance Imaging Measurements Are Associated With Clinical Outcomes at Three Years of Follow-Up: Results From a Prospective, International, Multi-Site Study of Patients With Significant Pulmonary Regurgitation Late After Tetralogy of Fallot Repair (2017) (0)
MULTIVESSEL REVASCULARIZATION IN PATIENTS WITH DIABETES AND ACUTE CORONARY SYNDROMES (2023) (0)
GENOTYPE-GUIDED P2Y12 INHIBITION FOLLOWING PCI BENEFITS CYP2C19 LOSS OF FUNCTION PATIENTS WITH NORMAL RENAL FUNCTION COMPARED TO THOSE WITH CHRONIC KIDNEY DISEASE (2021) (0)
Primary Care Clinical Volumes, Cholesterol Testing, and Cardiovascular Outcomes. (2022) (0)
820 Outcomes and Care of Patients With Acute Heart Failure Syndromes and Cardiac Troponin Elevation (2012) (0)
Improved long-term survival with coronary artery bypass graft surgery compared to percutaneous coronary intervention in diabetics with multivessel disease (2020) (0)
Abstract 17855: Risk Factors For 30-Day Outcome Following Multivessel Bypass Surgery in Diabetic Patients With Stable CAD: Pre-Operative Glycemic Control and Blood Pressure Management Matter (2013) (0)
Quality of Life After PCI vs CABGAmong Patients With Diabetes andMultivessel Coronary Artery Disease A Randomized Clinical Trial (2013) (0)
Angiography-Based Measurement of Myocardial Ischemia: Will Simpler Be Better? (2022) (0)
DIABETES MELLITUS PREDICTS FOR THE DEVELOPMENT OF RIGHT VENTRICULAR DYSFUNCTION POST ST-ELEVATION MYOCARDIAL INFARCTION (2015) (0)
Use of Noninvasive Combined MRI-PET/CT Imaging in dal-PLAQUE to Assess Dalcetrapib's Effects on Structural and Inflammatory Atherosclerotic Disease (2011) (0)
Paradoxical care delivery for patients with diabetes mellitus presenting with non–ST-Segment elevation acute coronary syndromes: Results from the CRUSADE quality improvement initiative (2004) (0)
CHARACTERISTIC DIFFERENCES IN LATE BREAKING CLINICAL TRIALS BETWEEN SIMULTANEOUS AND DELAYED PUBLICATION (2012) (0)
Imaging in diabetic cardiomyopathy (2014) (0)
Iconographies supplémentaires de l'article : Cardiovascular and cerebrovascular events among patients receiving omalizumab: Results from EXCELS, a prospective cohort study in moderate to severe asthma (2016) (0)
PRIOR CARDIOVASCULAR DISEASE, DIABETES AND CHRONIC KIDNEY DISEASE AND THE RISK OF RECURRENT CARDIOVASCULAR DISEASE FOLLOWING A MYOCARDIAL INFARCTION (2020) (0)
Editorial commentary: The need for a streamlined approach to STEMI management during the COVID-19 pandemic (2021) (0)
New-Onset Atrial Fibrillation in Sepsis Is Associated With Increased In-Hospital Mortality: Systematic Review and Meta-Analysis (2013) (0)
Research in a Department of Medicine in the COVID-19 Era (2020) (0)
Increased recurrent coronary heart disease and mortality risk among intensive medically managed patients following myocardial infarction (2016) (0)
Prognostic role of troponin T and troponin I in patients with acute coronary syndromes: Meta-analysis of 20 studies (2003) (0)
The Role of Primary Care Physician and Cardiologist Follow-Up for Patients With Chest Pain After Discharge From the Emergency Department (2013) (0)
Contents (2020) (0)
Sex‐Specific Differences in Clinical Outcomes After Percutaneous Coronary Intervention: Insights from the TAILOR‐PCI Trial (2022) (0)
Abstract 12754: Prevalence and Risk Factors of Carotid Vessel Wall Inflammation in Coronary Artery Disease Patients: An 18F-FDG PET / CT Imaging Study (2011) (0)
Screening for CAD in asymptomatic patients with type 2 diabetes did not reduce risk of cardiac events (2009) (0)
Carotid 18FDG-PET uptake independently predicts non-obstructive coronary artery disease as evaluated by CT coronary angiography (2010) (0)
The Peguero-Lo Presti criteria has the highest diagnostic accuracy for the diagnosis of left ventricular hypertrophy in the elderly (2020) (0)
Abstract 16404: Troponin is the Predominant Risk Factor for Mortality in Patients With Ischemic Heart Failure With Reduced or Preserved Ejection Fraction (2017) (0)
Abstract 14103: Comprehensive Risk Factor Control Improves Survival: The Bypass Angioplasty Revascularization Investigation 2 Diabetes (2011) (0)
Revascularization Strategies in Chronic Kidney Disease: Percutaneous Coronary Interventions Versus Coronary Artery Bypass Graft (2020) (0)
INFLAMMATION IN ARTERIAL VESSELS AND DIFFERENT FAT TISSUES AS PROSPECTIVELY ASSESSED BY 18F-FDG-PET/CT ARE HIGHLY CORRELATED (2013) (0)
Low survival after out-of-hospital cardiac arrest in nursing homes despite early initiation of bystander cardiopulmonary resuscitation-a nationwide study (0)
Diabetes: Making sense of the rosiglitazone controversy (2010) (0)
ACP Journal Club. Aspirin and/or antioxidants did not prevent CV events in diabetes and peripheral arterial disease. (2009) (0)
Use of the CANHEART ‘big data’ registry to conduct a large randomized registry clinical trial to improve lipid management in Ontario, Canada (2018) (0)
Chapter 43 – Diabetes and Cardiovascular Disease (2018) (0)
Transitioning a randomized controlled trial to a digital registry – experience from the TAILOR-PCI digital follow-up study on onboarding, engagement and geofencing consent rate (2020) (0)
DECLINE IN CORONARY HEART DISEASE INCIDENCE AND MORTALITY AMONG MIDDLE-AGED ADULTS WITH DIABETES FROM 1987-1993 THROUGH 2003-2009 (2013) (0)
Abstract P146: Trends in Recurrent Coronary Heart Disease Following Myocardial Infarction Among US Men and Women Between 2008 and 2016 (2019) (0)
Research Article Left ventricular hypertrophy by electrocardiography and echocardiography in the African American Study of Kidney Disease Cohort Study (2012) (0)
Implementing Digital Technology to Transitioning a Clinical Trial to a Registry – TAILOR-PCI Digital Study: Methods/Study Design (Preprint) (2021) (0)
Abstract 17268: The CHEER Chest Pain Unit Strategy Guides the Selective Use of Coronary Angiography and Revascularization and is Safe in Intermediate Risk Unstable Angina Patients Followed for 10 Years (2010) (0)
Abstract 18613: Utilization of High-Potency Statin Therapy Following Hospitalization for CHD Among Medicare Beneficiaries (2013) (0)
Abstract 16938: Late Gadolinium Enhancement on Cardiac Magnetic Resonance as Predictor of Overall Mortality in Patients With Non-Ischemic Cardiomyopathy (2018) (0)
Abstract 3155: C-reactive Protein Levels Are an Independent Predictor Of Mortality in Patients Undergoing Percutaneous Coronary Intervention (2008) (0)
Telmisartan and ramipril were equivalent, but their combination increased adverse events in vascular disease or diabetes (2008) (0)
DUAL- VERSUS MONO-ANTIPLATELET THERAPY IN PATIENTS UNDERGOING TAVR: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS AND OBSERVATIONAL STUDIES (2018) (0)
Recurrent Atherosclerotic Cardiovascular Disease Events Potentially Prevented with Guideline-Recommended Cholesterol-Lowering Therapy following Myocardial Infarction. (2023) (0)
Coronary atherosclerotic burden assessed by SYNTAX scores and outcomes in surgical, percutaneous or medical strategies: a retrospective cohort study (2022) (0)
Abstract 14578: Low Medication Adherence and Uncontrolled LDL-Cholesterol Among {per thousand}High Risk Us Adults Taking Statins: Data from the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study (2012) (0)
Diabetes and Coronary Artery Disease (2015) (0)
Abstract 12722: CABG Versus PCI in Patients with Diabetes: A Metaanalysis of Randomized Controlled Trials in the Era of Stents (2013) (0)
Abstract 20897: Patient-Reported Outcomes in Tetralogy of Fallot: Baseline Results From a Prospective, International, Multi-Site Study (2017) (0)
Development and Evaluation of Comprehensive Type II Diabetes Program Utilizing Board Certified Advanced Diabetes Managers in Primary Care (2019) (0)
Abstract 5212: Resolution of Pathological Q-waves is Associated With Improved Outcomes After Primary PCI for Acute Myocardial Infarction (2009) (0)
Abstract 1916: Atherosclerosis Inflammation Imaging With FDG-PET/CT is Highly Reproducibile in Carotid, Iliac and Femoral Arteries (2007) (0)
Abstract 19046: The Role of the SYNTAX Score in Predicting Clinical Outcome in Diabetic Patients After Percutaneous Coronary Intervention and Coronary Artery Bypass Graft: A FREEDOM Trial Sub-analysis (2017) (0)
Abstract 18274: Under Use of Statins and LDL-C Control Among People With a Framingham 10-Year Coronary Heart Disease Risk > 20% (2013) (0)
Abstract 16526: Arterial Wall Inflammation in Patients with Rheumatoid Arthritis is Equivalent to Coronary Artery Disease Patients without Autoimmune Disease (2012) (0)
Cardiovascular Effects of NSAIDS (2019) (0)
Abstract 4900: Left Ventricular Hypertrophy by Electrocardiography in the African-American Study of Kidney Disease and Hypertension (2009) (0)
High non-high-density lipoprotein cholesterol levels predict enhanced periprocedural inflammatory response following percutaneous coronary intervention in stable ischemic heart disease patients (2017) (0)
Getting to the heart of the matter: a trialist's approach to the use of nonsteroidal anti‑inflammatory drugs for patients with chronic pain syndromes. (2013) (0)
Corrigendum to 'Rationale and design of the comparison of outcomes and access to care for heart failure (COACH) trial: a stepped wedge cluster randomized trial' American Heart Journal 2021; 240:1-10. (2022) (0)
Development and validation of a model to categorize cardiovascular cause of death using health administrative data (2022) (0)
IMPLICATIONS OF POPULATION-BASED RECALIBRATION OF THE FRAMINGHAM RISK SCORE AND POOLED COHORT EQUATIONS IN ONTARIO, CANADA (2022) (0)
Abstract 10383: Comparative Assessment of Medical Therapy, PCI, or CABG on Clinical Outcomes in Diabetic Patients With Stable CAD According to Coronary Angiography and Left Ventricular Function: Patient-level Meta-analysis of the BARI-2D, COURAGE, and FREEDOM Trials (2015) (0)
Abstract 19212: Clinical Outcomes More Than 12 Months After PCI in Diabetic Patients With or Without DAPT: Results From the FREEDOM Trial (2016) (0)
THE LONG-TERM PROGNOSTIC IMPACT OF NEW-ONSET POSTOPERATIVE ATRIAL FIBRILLATION IN OLDER PATIENTS UNDERGOING CORONARY ARTERY BYPASS GRAFT SURGERY: A POPULATION-BASED ANALYSIS (2020) (0)
MS387 FDG-PET/CT AND MRI EVALUATION OF THE EFFECT OF DALCETRAPIB ON ATHEROSCLEROTIC PLAQUE PROGRESSION/REGRESSION: DESIGN OF THE DAL-PLAQUE STUDY (2010) (0)
Role of Multivessel Intervention in Diabetes Mellitus Advances in interventional procedures and medical therapy offer promising treatment options for the diabetic patient population. (2008) (0)
Abstract 17725: Frequency and Prognostic Importance of Troponin and CK-MB Elevations Following Coronary Artery Bypass Grafting: An Analysis from PRIMO I and PRIMO II (2012) (0)
VALIDATION AND PERFORMANCE OF POINT-OF-CARE RAPID CYP2C19 GENOTYPING IN THE TAILOR-PCI MULTICENTER INTERNATIONAL RANDOMIZED CLINICAL TRIAL (2021) (0)
COX-2 inhibitors and hypercoagulability. (2005) (0)
Contents (2020) (0)
Abstract 007: Titration From Low/moderate to High Intensity Statins Following Myocardial Infarction Among Patients With Diabetes (2017) (0)
P3422Contrasting the risk for atherosclerotic cardiovascular disease events among individuals with lower extremity peripheral artery disease, coronary heart disease and cerebrovascular disease (2019) (0)
Is there a role for troponin-I in the risk stratification of stable asymptomatic hemodialysis patients? (2002) (0)
Impact of smoking habit on clinical outcomes after percutaneous coronary intervention (2002) (0)
IMPROVED OUTCOMES WITH CARDIOLOGIST FOLLOW-UP AFTER EMERGENCY DEPARTMENT ASSESSMENT OF CHEST PAIN PATIENTS WITHOUT ESTABLISHED CARDIOVASCULAR DISEASE (2013) (0)
REmote moBile Outpatient mOnitoring in Transplant (Reboot) 2.0: a randomized control trial protocol (Preprint) (2020) (0)
Pulmonary Hypertension of Sickle Cell Disease Beyond (2014) (0)
Abstract 3620: Right Bundle Branch Block is associated with a high 15 year Mortality Rate in patients presenting with Chest Pain consistent with Unstable Angina - The Olmsted County Chest Pain Study (2007) (0)
DOES ST DEPRESSION PREDICT CORONARY OCCLUSION AFTER AN OUT-OF-HOSPITAL CARDIAC ARREST? (2015) (0)
CHARACTERIZING EARLY VS. LATE INTENSIVE CARE UNIT (ICU) ADMISSIONS IN PATIENTS HOSPITALIZED WITH HEART FAILURE (HF) (2016) (0)
The FIBRES Randomized Controlled Non-Inferiority Trial of Fibrinogen Concentrates versus Cryoprecipitate in Cardiac Surgery: Subgroup and Safety Analysis (2019) (0)
Abstract 15818: Willingness to Reinitiate Statins by Cardiovascular Disease Risk: Data From the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study (2016) (0)
Retraction notice to “Multi-vessel PCI in the Type II Diabetic: Who are appropriate candidate? Should there be country specific guidelines?” [J. Indian Coll. Cardiol. 5S1 (2015) S95–S103] (2016) (0)
Reply: Stroke Risk Following Anaortic Off-Pump CABG Versus PCI. (2018) (0)
Reply: Underutilization of High-Intensity Statin Therapy After Hospitalization for Coronary Heart Disease: A Cause for Concern, But a Few Words of Caution. (2015) (0)
Quality improvement and usability testing of the PortfolioDiet.app, a web-based health application to translate nutrition therapy for cardiovascular risk reduction in primary care (Preprint) (2021) (0)
Wednesday, 29 August 2012 (2012) (0)
/ Meta-analysis Cardiovascular Risk Factor Management Performance in Canada and the United States : A Systematic Review (2017) (0)
Coronary artery bypass grafting (2021) (0)
Aspirin and/or antioxidants did not prevent CV events in diabetes and peripheral arterial disease (2009) (0)
Abstract P109: Factoring Influencing Fruit and Vegetable Intake and Associations with Cardiovascular Disease Risk Factors: The Grenada Heart Project (2013) (0)
GLUCOSE LOWERING DRUGS OR STRATEGIES, MAJOR ADVERSE CARDIOVASCULAR EVENTS AND HEART FAILURE OUTCOMES, AND ASSOCIATION WITH WEIGHT LOSS - META-ANALYSIS OF LARGE CARDIOVASCULAR OUTCOME TRIALS (2019) (0)
Abstract 13464: Underutilization of Invasive Coronary Angiography Post Out of Hospital Cardiac Arrest: is a Paradigm Shift Needed? (2014) (0)
Contents (2020) (0)
Faculty Opinions recommendation of Intensive blood-pressure control in hypertensive chronic kidney disease. (2010) (0)
Nateglinide did not reduce diabetes or CV events in patients with impaired glucose tolerance and CV risk factors (2010) (0)
Revascularization Strategies in Patients with Diabetes and Acute Coronary Syndromes (2022) (0)
Abstract 344: Low Density Lipoprotein Cholesterol and Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention (2020) (0)
Abstract 14304: Assessing the Association of Adherence to Fractional Flow Reserve Treatment Thresholds and Outcomes of Patients With Coronary Artery Disease (2020) (0)
LIPOPROTEIN(A) PROTEIN CONCENTRATION AND APOLIPOPROTEIN(A) KRINGLE IV ISOFORMS AMONG BLACK US ADULTS WITH AND WITHOUT PCSK9 LOSS-OF-FUNCTION VARIANTS (2019) (0)
COMPARISON OF READMISSION AND DEATH AMONG CARDIAC PATIENTS IN NORTHERN VS. SOUTHERN ONTARIO (2018) (0)
Recurrent atherosclerotic cardiovascular disease events preventable with guideline recommended lipid-lowering treatment following myocardial infarction (2022) (0)
Research in a Department of Medicine in the COVID-19 Era (2020) (0)
Abstract 15962: Age, Sex, and Race Differences in Statin Discontinuation and Side Effect Patterns. The REasons for Geographic And Racial Differences in Stroke (REGARDS) Study (2016) (0)
Abstract 11903: The FREEDOM Trial: A Snapshot at Randomization (2011) (0)
Optimal Treatment of Patients With Left Ventricular Dysfunction and Severe Coronary Artery Disease (2018) (0)
Abstract 17894: Clinical and Electrocardiographic Predictors of Occlusive and Obstructive Coronary Artery Disease Following Out-of-Hospital Cardiac Arrest (2017) (0)
Valsartan reduced diabetes but not CV events in patients with impaired glucose tolerance and CV risk factors (2010) (0)
Abstract 17028: Neighborhood Income is Associated With Prevalence of Myocardial Infarction and Heart Failure Independent of Individual Demographic Factors in Densely Populated Urban Seniors (2013) (0)
Chapter 46 – Diabetes and Cardiovascular Disease (2010) (0)
Body mass index is the only independent predictor of different degrees of carotid wall inflammation as revealed by FDG-PET/CT imaging in patients with known or suspected cardiovascular disease (2010) (0)
Left main revascularization: breaking through the sounds of silence. (2022) (0)
Review: Lowering systolic BP to ≤ 135 mm Hg reduces CV events in type 2 diabetes/IFG/IGT (2011) (0)
Abstract P254: Willingness to Restart Statins: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study (2017) (0)
P2749Is relying on ST depression to help predict coronary artery disease after an out-of-hospital cardiac arrest harming patients? (2017) (0)
Abstract 12663: Risk Factor Control in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial (2010) (0)
A COGENT Argument for Gastrointestinal Protection With Low-Dose Aspirin. (2016) (0)
RETRACTED: Multi-vessel PCI in the type II diabetic: Who are appropriate candidate? Should there be country specific guidelines? (2015) (0)
IS SAME DAY DISCHARGE SAFE IN ELECTIVE PCI? RESULTS FROM A RANDOMIZED CONTROLLED STUDY (2011) (0)
Appropriate cardiac catheterization laboratory activation: Author reply (2011) (0)
CARDIOVASCULAR RISK AND UPTAKE OF EVIDENCE-BASED THERAPIES IN PATIENTS WITH TYPE 2 DIABETES AFTER AN ACUTE CARDIOVASCULAR EVENT: INSIGHTS FROM THE CANHEART REGISTRY (2021) (0)
Does PCI reduce the occurrence of 'hard' clinical endpoints in patients with stable coronary artery disease? (2005) (0)
Abstract 15724: Prevalence of Statin Use among Medicare Beneficiaries with Coronary Heart Disease by Income, Region, and Race/Ethnicity (2012) (0)
AIR QUALITY, OUTDOOR RUNNING AND VASCULAR DYSFUNCTION: A SYSTEMATIC REVIEW (2020) (0)
Length of stay is increased in subjects with chronic heart failure and elevated serum creatinine admitted to an inner city public hospital system (2004) (0)
Abstract MP85: Lifestyle and Biologic Factors and Risk for Recurrent Coronary Heart Disease Events (2013) (0)
ISCHEMIC AND BLEEDING OUTCOMES OF CARRIERS OF CYP2C19*17 TREATED WITH CLOPIDOGREL: INSIGHTS FROM THE TAILOR-PCI STUDY (2021) (0)
The Prognostic Influence of Left Bundle Branch Block in Unstable Angina (1998) (0)
Retraction notice to “Revascularization in type II diabetes: Challenges and evidence from clinical trials” [J. Indian Coll. Cardiol. 5S1 (2015) S76–S82] (2016) (0)
Greater likelihood of right-sided over left-sided carotid wall inflammation as revealed by FDG-PET/CT imaging (2010) (0)
Abstract 5213: Correlations Between Reciprocal ST-segment Depression on the Baseline Electrocardiogram, Angiographic Findings and Clinical Outcomes in Patients With STEMI Treated With Primary PCI (2009) (0)
Abstract 5015: Thrombolysis in Myocardial Infarction (TIMI) Risk Score and Mortality in Patients with Advanced Chronic Kidney Disease (CKD) and on Dialysis (2008) (0)
Abstract 10602: Baseline Clinical and Genetic Data Based Machine Learning Predictions of 1-Year Ischemic Outcomes Following Percutaneous Coronary Intervention (2021) (0)
PREDICTING LEFT MAIN STENOSIS IN CHRONIC CORONARY ARTERY DISEASE: IS IT FEASIBLE WITH TRADITIONAL OR MACHINE LEARNING MODELS? (2022) (0)
ACCURACY OF CARDIOVASCULAR TRIAL OUTCOME ASCERTAINMENT AND TREATMENT EFFECT ESTIMATES FROM ROUTINE HEALTH DATA: A SYSTEMATIC REVIEW AND META-ANALYSIS (2021) (0)
Faculty Opinions recommendation of Glucose control and vascular complications in veterans with type 2 diabetes. (2009) (0)
The Need for and Benefits of an International Database for Cardiac Tumors. (2020) (0)
IMPACT OF INTENSIVE PHARMACOTHERAPY ON ISCHEMIC HEART FAILURE OUTCOMES (2019) (0)
Abstract 15813: Perioperative CK-MB Elevation is a Better Predictor of Survival Than New Q Waves Among Diabetic Patients With Multivessel Coronary Artery Disease Undergoing CABG (2013) (0)
TRANSLATING CLINICAL TRIAL RESULTS INTO CLINICAL PRACTICE FOR PATIENTS WITH DIABETES AND MULTIVESSEL CORONARY ARTERY DISEASE IN BRITISH COLUMBIA: A POPULATION-BASED STUDY (2015) (0)
USEFULNESS OF ECG CRITERIA TO RULE OUT LEFT VENTRICULAR HYPERTROPHY IN OLDER INDIVIDUALS WITH TRUE LEFT BUNDLE BRANCH BLOCK (2021) (0)
TRENDS IN COMBINATION LIPID LOWERING THERAPY IN THE MEDICARE POPULATION WITH CORONARY HEART DISEASE (2015) (0)
RACE AND CLINICAL OUTCOMES AFTER PERCUTANEOUS CORONARY INTERVENTION: OBSERVATIONS FROM THE TAILOR-PCI TRIAL (2021) (0)
Quantitative dose-antithrombotic response of direct factor-Xa inhibitor ZK-807834 in stable coronary patients (2002) (0)
Abstract 871: Differences in Demographics Between Subjects in the Grenada Heart Project Survey and the Related Heart Health Fairs (2009) (0)
5191Recurrent coronary heart disease in the year following myocardial infarction among US men and women between 2008 and 2015 (2019) (0)
Abstract 2949: Atherosclerotic Plaque Inflammation is Highly Correlated with Serum Inflammatory Biomarker Levels - An FDG-PET/CT Imaging Study (2007) (0)
Randomized Trial of Anticoagulation Strategies for Noncritically Ill Patients Hospitalized With COVID-19 (2023) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Michael E. Farkouh?

Michael E. Farkouh is affiliated with the following schools:

Michael E. Farkouh's Academic­Influence.com Rankings

Why Is Michael E. Farkouh Influential?

Michael E. Farkouh's Published Works

Published Works

What Schools Are Affiliated With Michael E. Farkouh?

Michael E. Farkouh's AcademicInfluence.com Rankings